https://www.news-medical.net/news/2004/12/16/6878.aspx
Obesity drug codenamed AOD9604 highly successful in trials
Jun 19, 2019 - An Australian-owned obesity drug, developed by Melbourne-based biotechnology company Metabolic Pharmaceuticals Limited, is set to enter final human trials next...
obesity drugaod9604highlysuccessfultrials